Q&A: What does the Facebook acquisition of CTRL-Labs mean for Neurotechnology and Augmented & Virtual Reality?

By Avery Bedows | September 26, 2019

__________ While sit­ting at din­ner with an unsus­pect­ing friend, my phone blew up with odd­­­ly-late mes­sages from fel­low neu­rotech­nol­o­gy com­rades. CTRL-Labs announced their impend­ing acqui­si­tion by Face­book and inte­gra­tion into Face­book Real­i­ty Labs (respon­si­ble for Ocu­lus et al.), for enough mon­ey to buy my guilt-induc­ing­­ly-expen­­sive New York cof­fee for a mea­ger 550,000 years. Woah—so very many ques­tions. I…

Read More

Medical signal monitoring and display: Key Neurotech Patent #3

By SharpBrains | February 2, 2017
medial-signal-monitoring and display

Today we are shar­ing a 2001 patent assigned to Care­fu­sion 209, Inc. (As men­tioned, we are fea­tur­ing a foun­da­tion­al Per­va­sive Neu­rotech patent a day, from old­er to new­er by issue date) U.S. Patent No. 6,224,549: Med­ical sig­nal mon­i­tor­ing and dis­play Assignee(s): Care­fu­sion 209, Inc. Inventor(s): Wirm van Dron­ge­len Tech­nol­o­gy Cat­e­go­ry: EEG Issue Date: May 1, 2001 Sharp­Brains’ Take: The ‘549…

Read More